Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL

Approved

STANDARD

HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL

Roche Registration Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 29, 2024
Approval ID: eb9944d227062875
Company: Roche Registration Gmbh
Type: Standard

Approval Details

Approval Id: eb9944d227062875
Drug Cima Aemps Name: HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL
Register Number: 100145002IP1
Holder Company Name: Roche Registration Gmbh
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/roche-registration-gmbh
Authorization Date: 2024-05-29
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 600 mg/5 ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Roche Registration Gmbh
Company Detail Path: /organization/roche-registration-gmbh

Company Information

Pharmaceutical Company Name: Roche Registration GmbH
Country Name: Germany
City Name: grenzach-wyhlen,baden-württemberg,country_de
Address: Emil-Barell-Str. 1

Active Ingredients

TRASTUZUMAB

600 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 29, 2024

Approval ID

eb9944d227062875

Type

Standard

Back to CIMA-AEMPS Approvals